EC Number   |
Application |
Reference |
|---|
    1.14.18.1 | agriculture |
application of boron at high concentrations (10 and 20 mM) to maize seeds or even application very near to the seeds is not advisable |
690213 |
| 1.14.18.1 | biotechnology |
prepared CSG1.0 possesses macropores which permit fluid to pass through, and micropores in the skeleton of macropores which increase the specific surface area for ligands to immobilize on. These hybrid membranes could be used to immobilize ligands for affinity sorption. Advanced application of the hybrid membranes can be developed for application in tissue engineering, enzyme immobilization, catalysts support, fuel cells, etc. |
688305 |
| 1.14.18.1 | biotechnology |
the produced enzyme has similar properties as the one produced in the native Trichoderma reesei host and expression in the Pichia pastoris provides good opportunities for future protein engineering, screening and functional studies of this important class of enzymes |
689864 |
| 1.14.18.1 | drug development |
3-hydroxyphloretin and catechol isolated from the formosan apple, may be useful as cosmetic agents to stimulate skin whitening |
689413 |
| 1.14.18.1 | drug development |
acetazolamide is a good candidate for the inhibition of melanin biosynthesis. and might be used as a lead for developing the drugs for treatment of hyperpigmentary disorders and skin whitening |
744671 |
| 1.14.18.1 | drug development |
activators of tyrosinase with stimulatory effects on melanogenesis are beneficial for the treatment of hypopigmentation diseases. 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside is a potent tyrosinase activator and stimulator of melanogenesis with potential for the treatment of hypopigmentation disease |
689442 |
| 1.14.18.1 | drug development |
activators of tyrosinase with stimulatory effects on melanogenesis are beneficial for the treatment of hypopigmentation diseases. THSG is a potent tyrosinase activator and stimulator of melanogenesis with potential for the treatment of hypopigmentation disease |
689442 |
| 1.14.18.1 | drug development |
commercial plant extracts containing anthraquinones are being increasingly used for pharmaceuticals, foods and cosmetics due to their wide therapeutic and pharmacological properties |
689441 |
| 1.14.18.1 | drug development |
inhibitor 1-hydroxy-3-phenylurea is a promising candidate for preclinical drug development for skin hyperpigmentation application |
685604 |
| 1.14.18.1 | drug development |
kurarinol has the potential to be further developed as effective and safe anti-browning and skin-whitening agent |
689436 |
